Tumor necrosis factor (TNF) enhances the locomotion of low-density human tonsillar B lymphocytes through the selective triggering of type II receptor

Ann N Y Acad Sci. 1997 Apr 5:815:364-6. doi: 10.1111/j.1749-6632.1997.tb52085.x.
No abstract available

MeSH terms

  • Adenosine Triphosphatases*
  • Antigens, CD / metabolism
  • Apyrase
  • B-Lymphocytes / cytology*
  • Cell Movement / drug effects*
  • Flow Cytometry
  • Humans
  • Immunoglobulin D / metabolism
  • Palatine Tonsil / cytology*
  • Receptors, Tumor Necrosis Factor / metabolism*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Antigens, CD
  • Immunoglobulin D
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Adenosine Triphosphatases
  • Apyrase
  • CD39 antigen